Eight officer departures filed; three microcaps face delisting risk

Eight officer departures filed; three microcaps face delisting risk

Eight public companies disclosed officer departures in filings dated May 8, 2026, spanning healthcare, logistics, and consumer sectors. Edwards Lifesciences Corp (EW), FedEx Corp (FDX), Baxter International Inc (BAX), ADT Inc (ADT), Pool Corp (POOL), Nu Skin Enterprises Inc (NUS), Crescent Capital BDC Inc (CCAP), and an unnamed officer transition at Cryo Cell International Inc (CCEL) each filed Item 5.02 disclosures. Separately, three microcap companies—Cryo Cell International Inc (CCEL), Arrive AI Inc (ARAI), and Quetta Acquisition Corp (QETA)—registered delisting notices this week, with combined flagging scores of 13 to 14 across restatement and delisting metrics. La Rosa Holdings Corp (LRHC) posted the highest weekly aggregate score at 14, driven by restatement risk and delisting notices. Watch for follow-up 8-K amendments or rule compliance plans from CCEL, ARAI, and QETA within the next 10 trading days.